Text Size

Topical cyclosporine A cationic ophthalmic emulsion in paediatric vernal keratoconjunctivitis: pooled analysis of randomised NOVATIVE and VEKTIS trials

Leonardi A, Doan S, Aragona P,  Amrane M, Ismail D, Montero J, Németh J, Bremond-Gignac D


  • 2022
  • Eye (London)
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Categories

    Clinical development

  • Affiliations

    Department of Neuroscience, Ophthalmology Unit, University of Padua, Padua, Italy. andrea.leonardi@unipd.it; Bichat Hospital and Foundation A. de Rothschild, Paris, France; Department of Biomedical Sciences, Ophthalmology Clinic, University of Messina, Messina, Italy; Santen SAS, Evry, France; Universidad de Sevilla, Seville, Spain; Department of Ophthalmology, Semmelweis University, Budapest, Hungary; Department of Ophthalmology, University Hospital Necker Enfants Malades, APHP, Paris, France; INSERM Unit 1138, T17 Paris Cité University, Paris, France

Related Publications

The FAST Study: Examining Quality of Vision Outcomes in Dry Eye Disease Patients with Severe Keratitis Treated with the Ciclosporin A Cationic Emulsion

Pisella P.-J., Mourad A., Ismail D., Garrigue J.-S., Cochener B.


Six-month efficacy and safety of oxymetazoline hydrochloride 0.1% in Japanese patients with acquired blepharoptosis: a phase 3 study

Ishikawa H., Oka K., Inoue H.


Tear Biomarkers of Topical Sirolimus in Meibomian Gland Dysfunction: A Randomized Trial

Zhou L.; Shimizu H.; Togashi Y.; Kirihara T.; Yang Y.; Lam C.T.; Shimada H.; Tong L.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022